A 12-week, randomized, double-blind, placebo-controlled clinical trial will be conducted evaluating the effectiveness of Enviromedica - Terraflora Daily Care on markers of gastrointestinal function and symptoms.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Enrollment
40
12 weeks of supplementation with Enviromedica - Terraflora Daily Care
Placebo capsule
GA-Map Dysbiosis Test
Time frame: 4 weeks, 12 weeks
Percentage of participants with dysfunction on GI360 Profile
Time frame: 4 weeks, 12 weeks
Percentage of participants with dysfunction on Thorne Gut Health Test
Time frame: 4 weeks, 12 weeks
Gastrointestinal Symptom Rating Scale
Minimum value: 1, Maximum value: 7, Higher scores represent more severe/troublesome symptoms.
Time frame: 4 weeks, 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.